Anemia, Refractory - 25 Studies Found Active, not recruiting : DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia : Acute Myeloid Leukemia Alkylating Agent-Related Acute Myeloid Leukemia Biological: DEC-205/NY-ESO-1 Fusion Protein CDX-1401 Completed : Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome : Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Myeloid Leukemia in Remission : 2000-03-07 : Biological: PR1 leukemia peptide vaccine Completed : PS-341 in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia in Blast Phase, or Myelodysplastic Syndrome : Adult Acute Promyelocytic Leukemia (M3) Blastic Phase Chronic Myelogenous Leukemia : 2000-04-06 : Drug: bortezomib Given IV Other Names: Completed : Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies : Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Myeloid Leukemia in Remission : 2010-08-03 : Procedure: umbilical cord blood transplantation Active, not recruiting : Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome : Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia Wit : 2005-07-12 : Radiation: iodine I 131 monoclonal antibody BC8 <<< Previous
